https://www.marketscreener.com/quote/stock/SPRINGWORKS-THERAPEUTICS--65542668/news/SpringWorks-Therapeutics-Announces-Phase-1b-2a-Clinical-Trial-of-Mirdametinib-in-Patients-with-Advan-36066706/?utm_source=telegram&utm_medium=social&utm_campaign=share